Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.
Zacks Investment Research on MSN
Bet on these 3 stocks with upgraded broker ratings amid uncertainties
As the U.S. economy continues to face sticky inflation and softening job growth, the chances of the Federal Reserve cutting interest rates are high now. Alternatively, tariffs, supply-chain pressures ...
The global genomics market is set to expand from USD 47.07 billion in 2025 to USD 85.09 billion by 2030, with a CAGR of 12.6% ...
The next generation sequencing market offers significant opportunities by enhancing the diagnosis and treatment of chronic ...
A team from the Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER) has developed an innovative ...
The 24th HUPO World Congress showed a field growing beyond mass spectrometry and starting to think in terms of impact of its ecosystems.
Single-cell sequencing provides unprecedented detail into cell-to-cell variability, uncovering key biological mechanisms in ...
The global genomics market is projected to expand by 15-17% by 2029. Key factors driving this growth include the increasing ...
Quest Diagnostics appoints new leader for Blueprint. Juhana Rauramo is in as vice president and general manager for Blueprint ...
China’s life sciences industry is entering a transformative era, with a clear focus on pharmaceutical innovation, precision diagnosis, and health management. This evolution lies in genomic sequencing ...
Centuries-old genetic material can solve historical mysteries, from lost species to what killed Napoleon’s army.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results